MEDOCHEMIE LTD (CYPRUS)🇸🇬 Health Sciences Authority
Approval Date
Apr 30, 1996
Approval ID
afbda6bfbefbbbdd
Company
MEDOCHEMIE LTD (CYPRUS)
Type
Therapeutic
Approval Details
Approval Id
afbda6bfbefbbbdd
Drug Name
SELEGOS TABLET 5 MG
Product Name
SELEGOS TABLET 5 MG
Approval Number
SIN08681P
Approval Date
1996-04-30
Registrant
MEDOCHEMIE SINGAPORE PTE. LTD.
Licence Holder
MEDOCHEMIE SINGAPORE PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
TABLET
Dosage
<p><strong>4.2. Posology and method of administration</strong></p>
<p>SELEGOS 10mg (2 tablets) daily either alone or as an adjunct to levodopa or levodopa/peripheral decarboxylase inhibitor.<br>
SELEGOS may be administered either as a single dose in the morning or in two divided doses of 5mg taken at breakfast and lunch.<br>
When SELEGOS is added to a levodopa regimen it is possible to reduce the levodopa dosage by an average of 30 percent.</p>
Route Of Administration
ORAL
Indication Info
<p><strong>4.1. Therapeutic indications</strong></p>
<p>SELEGOS is indicated for the treatment of Parkinson’s disease or symptomatic parkinsonism.<br>
SELEGOS may be used alone in early Parkinson’s disease to delay the need for levodopa (with or without decarboxylase inhibitor). SELEGOS may also be used as an adjunct to levodopa (with or without decarboxylase inhibitor).</p>
